Literature DB >> 19422802

Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.

Yota Tatara1, Yi-Chin Lin, Yoshimasa Bamba, Tadashi Mori, Takafumi Uchida.   

Abstract

Pin1 is involved in eukaryotic cell proliferation by changing the structure and function of phosphorylated proteins. PiB, the Pin1 specific inhibitor, blocks cancer cell proliferation. However, low solubility of PiB in DMSO has limited studies of its effectiveness. We screened for additional Pin1 inhibitors and identified the DMSO-soluble compound dipentamethylene thiuram monosulfide (DTM) that inhibits Pin1 activity with an EC50 value of 4.1 microM. Molecular modeling and enzyme kinetic analysis indicated that DTM competitively inhibits Pin1 activity, with a K(i) value of 0.05 microM. The K(D) value of DTM with Pin1 was determined to be 0.06 microM by SPR technology. Moreover, DTM specifically inhibited peptidyl-prolyl cis/trans isomerase activity in HeLa cells. FACS analysis showed that DTM induced G0 arrest of the HCT116 cells. Our results suggest that DTM has the potential to guide the development of novel antifungal and/or anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19422802     DOI: 10.1016/j.bbrc.2009.04.144

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2 (FGF2)-induced osteoblast differentiation.

Authors:  Won-Joon Yoon; Young-Dan Cho; Woo-Jin Kim; Han-Sol Bae; Rabia Islam; Kyung-Mi Woo; Jeong-Hwa Baek; Suk-Chul Bae; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

2.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.

Authors:  Tao Liu; Yu Liu; Hung-Ying Kao; Dehua Pei
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

3.  A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.

Authors:  Bisheng Jiang; Dehua Pei
Journal:  J Med Chem       Date:  2015-07-28       Impact factor: 7.446

Review 4.  The regulatory role of Pin1 in neuronal death.

Authors:  Shu-Chao Wang; Xi-Min Hu; Kun Xiong
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

5.  Pin1-mediated Runx2 modification is critical for skeletal development.

Authors:  Won-Joon Yoon; Rabia Islam; Young-Dan Cho; Kyung-Mi Woo; Jeong-Hwa Baek; Takafumi Uchida; Toshihisa Komori; Andre van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein; Je-Yong Choi; Suk-Chul Bae; Hyun-Mo Ryoo
Journal:  J Cell Physiol       Date:  2013-12       Impact factor: 6.384

6.  Prolyl isomerase Pin1 regulates mouse embryonic fibroblast differentiation into adipose cells.

Authors:  Takafumi Uchida; Kengo Furumai; Tomokazu Fukuda; Hirotada Akiyama; Mika Takezawa; Tomoichiro Asano; Fumihiro Fujimori; Chiyoko Uchida
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

7.  Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation.

Authors:  J Marsolier; M Perichon; J D DeBarry; B O Villoutreix; J Chluba; T Lopez; C Garrido; X Z Zhou; K P Lu; L Fritsch; S Ait-Si-Ali; M Mhadhbi; S Medjkane; J B Weitzman
Journal:  Nature       Date:  2015-01-26       Impact factor: 49.962

8.  The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins.

Authors:  Nithya Krishnan; Mark A Titus; Roopa Thapar
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

9.  Pin1 is related with clinical stage of papillary thyroid carcinoma.

Authors:  Lixin Jiang; Haidi Chu; Haitao Zheng
Journal:  World J Surg Oncol       Date:  2016-03-31       Impact factor: 2.754

10.  Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.

Authors:  Luana D'Artista; Andrea Bisso; Andrea Piontini; Mirko Doni; Alessandro Verrecchia; Theresia R Kress; Marco J Morelli; Giannino Del Sal; Bruno Amati; Stefano Campaner
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.